Fostering a Team-Based Approach to Elevate Neuro-Oncology Care

Commentary
Video

Specialties including neurosurgery, radiation oncology, and neuro-rehabilitation all play a notable role in the care of patients with brain tumors.

Sylvia Kurz, MD, PhD, spoke with CancerNetwork® about the importance of collaborating with multiple disciplines to elevate the level of care and meet the needs of patients with brain tumors.

According to Kurz, an associate professor of Neurology (Neuro-Oncology) as part of the Chênevert Family Brain Tumor Center at Smilow Cancer Hospital and Yale Cancer Center, she works with members from the neurosurgery, radiation oncology, and neuro-rehabilitation departments to ensure that patients regain strength and functionality for day-to-day living as they undergo treatment for their disease. Additionally, multidisciplinary collaboration includes the involvement of palliative care services, social workers, and psychological counselors, which may help patients and their loved ones cope with diagnoses and treatments.

Transcript:

It does take a village in neuro-oncology to provide good care to patients. All [types of] specialties are part of our team approach. I'd say the vast majority of my patients will see multiple specialties very early on in their illnesses. That includes neurosurgery, radiation oncology, me, and neuro-rehabilitation. Most of our patients will go to rehab after initial resection or if they're readmitted. It's a very common thing to send them to rehab to regain strength and functionality in daily activities.

[Regarding] palliative care, many of my patients are involved with palliative care services early on. I would also say that many neuro-oncologists feel very comfortable providing palliative care, meaning symptom-oriented care, themselves to those patients. I would also say towards the end of life that we don't rely on palliative care services to have those discussions, but we...are always part of these discussions, as we should be. Yes, we do work a lot with social workers and psychological counselors to help patients and their families cope with their diagnosis and treatments.

This is the center of what we do, and we involve multidisciplinary teams for most of our patients.

Recent Videos
Treatment-related toxicities during neuro-oncology therapy appear well managed with dose modifications and treatment cycle holds.
CAR T-cell therapies appear to be an evolving modality in the treatment of those with intracranial tumors, said Sylvia Kurz, MD, PhD.
According to Maurie Markman, MD, patient-reported outcomes pertain to more relevant questions surrounding the impact of therapy for patients.
CancerNetwork® spoke with Neha Mehta-Shah, MD, MSCI, about the clinical landscape for patients undergoing treatment for rare lymphomas.
Future findings from a translational analysis of the OVATION-2 trial may corroborate prior clinical data with IMNN-001 in advanced ovarian cancer.
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.